Form 4: ClearPoint Neuro CFO Disposes of Shares for Tax Obligations Following Restricted Stock Vesting
Insider Transaction Report
ClearPoint Neuro, Inc.'s Chief Financial Officer, Danilo D'Alessandro, reported the disposition of 4,754 shares of common stock valued at $13.29 per share to cover tax withholding obligations related to the vesting of restricted stock.
Summary
- Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro, Inc. (CLPT), reported a transaction on June 10, 2025.
- The transaction involved the disposition of 4,754 shares of ClearPoint Neuro common stock.
- The shares were disposed of at a price of $13.29 per share.
- This disposition was made to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock.
- Following this transaction, Mr. D'Alessandro beneficially owns 65,992 shares of ClearPoint Neuro common stock directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine, legally mandated disclosure of an insider transaction for tax purposes, which is a common occurrence and does not typically indicate a positive or negative outlook on the company's performance.
Negatives
- The transaction involved a disposition of 4,754 shares by a key executive, which reduces their direct ownership, although it is for tax purposes.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine compliance disclosure for an insider stock transaction, common across all publicly traded companies when executives' restricted stock vests and shares are withheld for tax purposes. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The transaction is a routine compliance filing and is unlikely to have a significant direct impact on shareholders, as it represents a standard tax-related disposition rather than a discretionary sale.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of transaction (disposition of shares). |
| 06/12/2025 | Date the Form 4 was signed by the reporting person. |
Keywords
ClearPoint Neuro, CLPT, Form 4, Insider Transaction, Danilo D'Alessandro, Chief Financial Officer, Restricted Stock, Tax Withholding, Stock Disposition, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.